Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
Completed · Phase 2
Conditions studied: Fuchs' Dystrophy, Bullous Keratopathy
In brief
The purpose of this study is to compare two different commonly used steroid dosing regimens after Descemet's membrane endothelial keratoplasty (DMEK) transplant surgery. The investigators hope to determine if one is more effective at preventing rejection or if both are equally effective.
Key facts
- Study ID
- NCT01448213
- Run by
- Price Vision Group
- People needed
- 264
- Starts
- 2011-10-01
- Expected to finish
- 2014-01-01
- Last updated by the study team
- 2014-09-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Price Vision Group — Indianapolis, Indiana, United States
- University of Erlangen — Erlangen, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.